>
Biosearch SA logo

BIO - Biosearch SA Share Price

€2.14 -0.0  -0.5%

Last Trade - 16/04/21

Sector
Consumer Defensives
Size
Small Cap
Market Cap £106.1m
Enterprise Value £101.8m
Revenue £22.4m
Position in Universe 360th / 729
Bullish
Bearish
Unlock BIO Revenue
Momentum
Relative Strength (%)
1m -3.32%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.93%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
19.2 22.8 25.3 26.7 22.8 25.8 30.8 34.7 +6.1%
+309.7 +9.3 -86.0 +239.4 +46.4 +50.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Biosearch SA revenues increased 13% to EUR25.8M. Net incomeincreased from EUR507K to EUR1.5M. Revenues reflect ProductSales segment increase of 15% to EUR25.3M, Other Countriessegment increase of 44% to EUR7.9M, Other European Unionsegment increase of 4% to EUR12.8M. Net income benefitedfrom Social Expense decrease of 8% to EUR1.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIO Revenue Unlock BIO Revenue

Net Income

BIO Net Income Unlock BIO Revenue

Normalised EPS

BIO Normalised EPS Unlock BIO Revenue

PE Ratio Range

BIO PE Ratio Range Unlock BIO Revenue

Dividend Yield Range

BIO Dividend Yield Range Unlock BIO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BIO EPS Forecasts Unlock BIO Revenue
Profile Summary

Biosearch SA, formerly Puleva Biotech SA, is a Spain-based company primarily engaged in the research, development and commercialization of functional food products based on natural ingredients aimed at the consecution of health positive effects that may improve the quality of life. The Company specializes in the nutrition research, which includes patents on infant formulas; the process for extraction and purification of Omega-3 acids; biotechnology projects focused on the microbial fermentation, enzymatic transformations and purification of functional lipids, and the development of functional dairy products, healthy fats, probiotics bacteria and antioxidants, among others, which are distributed under the Eupoly-Epa and Hereditum brands.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 13, 2000
Public Since November 28, 2001
No. of Shareholders: n/a
No. of Employees: 140
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange Madrid Stock Exchange
Shares in Issue 57,194,625
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIO
Upcoming Events for BIO
Frequently Asked Questions for Biosearch SA
What is the Biosearch SA share price?

As of 16/04/21, shares in Biosearch SA are trading at €2.14, giving the company a market capitalisation of £106.1m. This share price information is delayed by 15 minutes.

How has the Biosearch SA share price performed this year?

Shares in Biosearch SA are currently trading at €2.14 and the price has moved by 0.106k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosearch SA price has moved by 59.45% over the past year.

What are the analyst and broker recommendations for Biosearch SA?

Of the analysts with advisory recommendations for Biosearch SA, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Biosearch SA is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Biosearch SA next release its financial results?

Biosearch SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Biosearch SA dividend yield?

Biosearch SA does not currently pay a dividend.

Does Biosearch SA pay a dividend?

Biosearch SA does not currently pay a dividend.

When does Biosearch SA next pay dividends?

Biosearch SA does not currently pay a dividend.

How do I buy Biosearch SA shares?

To buy shares in Biosearch SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biosearch SA?

Shares in Biosearch SA are currently trading at €2.14, giving the company a market capitalisation of £106.1m.

Where are Biosearch SA shares listed? Where are Biosearch SA shares listed?

Here are the trading details for Biosearch SA:

Country of listing: Spain
Exchange: MCE
Ticker Symbol: BIO
What kind of share is Biosearch SA?

Based on an overall assessment of its quality, value and momentum, Biosearch SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biosearch SA share price forecast 2021?

We were not able to load any forecast data for Biosearch SA.

How can I tell whether the Biosearch SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosearch SA. Over the past six months, the relative strength of its shares against the market has been 29.32%. At the current price of €2.14, shares in Biosearch SA are trading at 40.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biosearch SA PE Ratio?

The Biosearch SA PE ratio based on its reported earnings over the past 12 months is 78.33. The shares are currently trading at €2.14.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Biosearch SA?

Biosearch SA's management team is headed by:

Jose Maria Roset Monros - GED
Erick Boutry - DRC
Alejandro Jara Garcia Navas - COO
Aurelio Antuna Rodriguez - CHM
Monica Maria Olivares Martin - OTH
Jose Cerezuela Rodriguez - DRC
Isidoro Martinez de la Escalera Alvarez - IND
Ana Maria Moreno Jimenez - OTH
Emma Madrid Sanchez-Gomez - DHR
Jaime Lancha Fernandez - OTH
Loreto Huertas de la Camara - CFO
Maria Jesus Alonso del Hoyo - IND
Antonio Jesus Tornero Martos - OTH
Maria Cobian Lareo - SEC
Who are the major shareholders of Biosearch SA?

Here are the top five shareholders of Biosearch SA based on the size of their shareholding:

Besnier Emmanuel (Georges Philippe) Individual Investor
Percentage owned: 29.5% (17.0m shares)
Pescaderías Coruñesas Corporation
Percentage owned: 9.01% (5.20m shares)
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund
Percentage owned: 4.94% (2.85m shares)
Syquant Capital S.A.S Investment Advisor
Percentage owned: 1.78% (1.03m shares)
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund
Percentage owned: 1.44% (831k shares)
Similar to BIO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.